Healthcare provider profile · identity verified

Gary Robert Burman, M.D.

Internal Medicine · CHANNELVIEW, TX · NPI 1700851557

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	441	44
Atorvastatin Calcium	Atorvastatin Calcium	395	64
Levothyroxine Sodium	Levothyroxine Sodium	317	40
Furosemide	Furosemide	299	50
Potassium Chloride	Potassium Chloride	255	35
Gabapentin	Gabapentin	224	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	192	56
Famotidine	Famotidine	190	27
Sertraline Hcl	Sertraline Hcl	182	26
Buspirone Hcl	Buspirone Hcl	174	27
Metformin Hcl	Metformin Hcl	155	23
Pantoprazole Sodium	Pantoprazole Sodium	139	30
Escitalopram Oxalate	Escitalopram Oxalate	133	16
Amlodipine Besylate	Amlodipine Besylate	132	27
Lisinopril	Lisinopril	127	24
Clopidogrel	Clopidogrel Bisulfate	109	20
Metoprolol Tartrate	Metoprolol Tartrate	107	26
Quetiapine Fumarate	Quetiapine Fumarate	107	15
Mirtazapine	Mirtazapine	106	23
Levetiracetam	Levetiracetam	99	13
Metoprolol Succinate	Metoprolol Succinate	98	18
Tamsulosin Hcl	Tamsulosin Hcl	97	20
Trazodone Hcl	Trazodone Hcl	96	18
Carvedilol	Carvedilol	95	16
Memantine Hcl	Memantine Hcl	90	11
Omeprazole	Omeprazole	77	14
Divalproex Sodium	Divalproex Sodium	74	15
Donepezil Hcl	Donepezil Hcl	74	13
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	65	23
Meloxicam	Meloxicam	65	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	64	suppressed
Montelukast Sodium	Montelukast Sodium	64	11
Gemtesa	Vibegron	61	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	61	11
Torsemide	Torsemide	61	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	60	32
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	14
Tramadol Hcl	Tramadol Hcl	55	15
Ziprasidone Hcl	Ziprasidone Hcl	55	suppressed
Alendronate Sodium	Alendronate Sodium	54	suppressed
Duloxetine Hcl	Duloxetine Hcl	54	suppressed
Fluticasone Propionate	Fluticasone Propionate	53	23
Jardiance	Empagliflozin	52	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	49	suppressed
Citalopram Hbr	Citalopram Hydrobromide	47	suppressed
Amiodarone Hcl	Amiodarone Hcl	45	suppressed
Simvastatin	Simvastatin	45	suppressed
Pregabalin	Pregabalin	43	13
Ropinirole Hcl	Ropinirole Hcl	42	suppressed
Januvia	Sitagliptin Phosphate	41	suppressed
Nystatin	Nystatin	41	15
Metoclopramide Hcl	Metoclopramide Hcl	40	suppressed
Paroxetine Hcl	Paroxetine Hcl	39	suppressed
Humalog Kwikpen U-100	Insulin Lispro	38	suppressed
Ibuprofen	Ibuprofen	38	suppressed
Latanoprost	Latanoprost	34	suppressed
Losartan Potassium	Losartan Potassium	33	suppressed
Prednisone	Prednisone	33	15
Combivent Respimat	Ipratropium/Albuterol Sulfate	32	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	32	11
Bupropion Hcl Sr	Bupropion Hcl	31	suppressed
Ondansetron Hcl	Ondansetron Hcl	31	23
Spironolactone	Spironolactone	31	suppressed
Allopurinol	Allopurinol	30	suppressed
Loperamide	Loperamide Hcl	30	14
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Benztropine Mesylate	Benztropine Mesylate	28	suppressed
Fluconazole	Fluconazole	28	13
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Flecainide Acetate	Flecainide Acetate	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Clobetasol Propionate	Clobetasol Propionate	26	suppressed
Albuterol Sulfate	Albuterol Sulfate	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Glipizide	Glipizide	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Cilostazol	Cilostazol	22	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	22	suppressed
Lactulose	Lactulose	22	suppressed
Olanzapine	Olanzapine	22	suppressed
Ondansetron Odt	Ondansetron	22	15
Sucralfate	Sucralfate	22	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Celecoxib	Celecoxib	21	suppressed
Formoterol Fumarate	Formoterol Fumarate	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	20	12
Arexvy	Rsvpref3 Antigen/As01e/Pf	20	20
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Baclofen	Baclofen	19	suppressed
Eszopiclone	Eszopiclone	19	suppressed
Insulin Aspart Flexpen	Insulin Aspart	19	suppressed
Megestrol Acetate	Megestrol Acetate	19	suppressed
Midodrine Hcl	Midodrine Hcl	19	suppressed
Oxcarbazepine	Oxcarbazepine	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Belsomra	Suvorexant	18	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Digoxin	Digoxin	17	suppressed
Dropsafe Pen Needle	Pen Needle, Diabetic, Safety	17	suppressed
Levofloxacin	Levofloxacin	17	14
Nystop	Nystatin	17	12
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	13
Clonidine Hcl	Clonidine Hcl	16	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	16	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	16	suppressed
Levemir Flexpen	Insulin Detemir	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Glyburide-Metformin Hcl	Glyburide/Metformin Hcl	14	suppressed
Glyxambi	Empagliflozin/Linagliptin	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Linzess	Linaclotide	14	suppressed
Novofine Autocover	Pen Needle, Diabetic, Safety	14	suppressed
Prazosin Hcl	Prazosin Hcl	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Azithromycin	Azithromycin	13	13
Cephalexin	Cephalexin	13	11
Finasteride	Finasteride	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Lacosamide	Lacosamide	13	suppressed
Ozempic	Semaglutide	13	suppressed
Risperidone	Risperidone	13	suppressed
Sodium Chloride	Sodium Chloride Irrig Solution	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Admelog Solostar	Insulin Lispro	12	suppressed
Alprazolam	Alprazolam	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Budesonide	Budesonide	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Trospium Chloride	Trospium Chloride	12	suppressed
Cefdinir	Cefdinir	11	suppressed
Cyclosporine	Cyclosporine	11	suppressed
Diazepam	Diazepam	11	suppressed
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Enulose	Lactulose	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Scopolamine	Scopolamine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error